REDMOND, WA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The End Brain Cancer Initiative Partners with Belay ...

The study, published in Nature Medicine, demonstrates that the Guardant360® test helps identify patients who may benefit from treatment and can identify alterations that predict resistance The study, ...

Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

The program enlists new technology that captures and preserves tumor cells typically discarded during routine biopsy ...

The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with ...

Routine screening is limited to only a few cancer types. New research indicates that routine liquid biopsy testing (multi-cancer early detection testing) could substantially reduce late-stage cancer ...

Exclusive: DNA test means patients could be offered most effective treatment first, boosting their chances of beating the disease ...

The global liquid biopsy market is experiencing substantial growth, driven by increasing demand for non-invasive diagnostic technologies that detect molecular biomarkers using liquid samples, thus ...

DUBLIN--(BUSINESS WIRE)--The "Worldwide Market for Liquid Biopsy, 6th Edition" report has been added to ResearchAndMarkets.com's offering. Liquid biopsies have emerged as a minimally invasive ...

During the 6 month period of the study, 1432 duodenal biopsies were received where celiac disease was part of the differential specified in the pathology request. Less than one-third of these patients ...